News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
282,423 Results
Type
Article (14923)
Company Profile (300)
Press Release (267194)
Multimedia
Podcasts (78)
Webinars (11)
Section
Business (80103)
Career Advice (163)
Deals (13399)
Drug Delivery (39)
Drug Development (50788)
Employer Resources (31)
FDA (5850)
Job Trends (5204)
News (145493)
Policy (10092)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (2)
Academia (923)
Accelerated approval (19)
Adcomms (14)
Allergies (81)
Alliances (21817)
ALS (125)
Alzheimer's disease (1036)
Antibody-drug conjugate (ADC) (241)
Approvals (6045)
Artificial intelligence (259)
Autoimmune disease (111)
Automation (9)
Bankruptcy (105)
Best Places to Work (4595)
BIOSECURE Act (6)
Biosimilars (100)
Biotechnology (231)
Bladder cancer (101)
Brain cancer (45)
Breast cancer (344)
Cancer (3132)
Cardiovascular disease (237)
Career advice (148)
Career pathing (7)
CAR-T (217)
CDC (5)
Cell therapy (563)
Cervical cancer (14)
Clinical research (43740)
Collaboration (1149)
Company closure (2)
Compensation (596)
Complete response letters (39)
COVID-19 (1101)
CRISPR (86)
C-suite (550)
Cystic fibrosis (112)
Data (4324)
Denatured (15)
Depression (94)
Diabetes (254)
Diagnostics (1383)
Digital health (10)
Diversity (5)
Diversity, equity & inclusion (9)
Drug discovery (188)
Drug pricing (48)
Drug shortages (3)
Duchenne muscular dystrophy (215)
Earnings (31767)
Editorial (25)
Employer branding (4)
Employer resources (29)
Events (51780)
Executive appointments (623)
FDA (7605)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (9)
Frontotemporal dementia (22)
Funding (981)
Gene editing (182)
Generative AI (21)
Gene therapy (487)
GLP-1 (505)
Government (1151)
Grass and pollen (3)
Guidances (167)
Healthcare (6640)
HIV (18)
Huntington's disease (43)
IgA nephropathy (74)
Immunology and inflammation (190)
Immuno-oncology (39)
Indications (66)
Infectious disease (1205)
Inflammatory bowel disease (157)
Inflation Reduction Act (10)
Influenza (38)
Intellectual property (166)
Interviews (18)
IPO (7378)
IRA (12)
Job creations (870)
Job search strategy (130)
JPM (40)
Kidney cancer (9)
Labor market (22)
Layoffs (243)
Leadership (9)
Legal (1403)
Liver cancer (41)
Longevity (11)
Lung cancer (422)
Lymphoma (249)
Machine learning (24)
Management (7)
Manufacturing (376)
MASH (130)
Medical device (2723)
Medtech (2732)
Mergers & acquisitions (6645)
Metabolic disorders (724)
Multiple sclerosis (104)
NASH (13)
Neurodegenerative disease (231)
Neuropsychiatric disorders (70)
Neuroscience (1960)
Neurotech (1)
NextGen: Class of 2026 (2043)
Non-profit (871)
Now hiring (30)
Obesity (329)
Opinion (125)
Ovarian cancer (131)
Pain (102)
Pancreatic cancer (161)
Parkinson's disease (232)
Partnered (12)
Patents (301)
Patient recruitment (330)
Peanut (43)
People (26720)
Pharmaceutical (44)
Pharmacy benefit managers (6)
Phase 1 (15504)
Phase 2 (20318)
Phase 3 (12843)
Pipeline (3257)
Policy (90)
Postmarket research (853)
Preclinical (6542)
Press Release (30)
Prostate cancer (145)
Psychedelics (50)
Radiopharmaceuticals (238)
Rare diseases (648)
Real estate (1462)
Recruiting (12)
Regulatory (9911)
Reports (19)
Research institute (974)
Resumes & cover letters (18)
Rett syndrome (24)
RNA editing (21)
RSV (16)
Schizophrenia (123)
Series A (182)
Series B (136)
Service/supplier (1)
Sickle cell disease (77)
Special edition (18)
Spinal muscular atrophy (119)
Sponsored (15)
Startups (2008)
State (1)
Stomach cancer (5)
Supply chain (32)
Tariffs (18)
The Weekly (62)
Vaccines (333)
Venture capital (69)
Weight loss (173)
Women's health (25)
Worklife (2)
Date
Today (25)
Last 7 days (340)
Last 30 days (1141)
Last 365 days (17835)
2026 (1678)
2025 (18111)
2024 (20586)
2023 (22458)
2022 (26887)
2021 (27911)
2020 (23473)
2019 (16337)
2018 (11811)
2017 (13808)
2016 (11876)
2015 (14384)
2014 (10425)
2013 (7497)
2012 (7540)
2011 (7631)
2010 (7437)
Location
Africa (155)
Alabama (65)
Alaska (2)
Arizona (71)
Arkansas (5)
Asia (18325)
Australia (3116)
California (7093)
Canada (1837)
China (773)
Colorado (246)
Connecticut (252)
Delaware (235)
Europe (39218)
Florida (903)
Georgia (213)
Hawaii (2)
Idaho (17)
Illinois (396)
India (35)
Indiana (160)
Iowa (8)
Japan (222)
Kansas (80)
Kentucky (9)
Louisiana (8)
Maine (11)
Maryland (736)
Massachusetts (5589)
Michigan (110)
Minnesota (247)
Mississippi (3)
Missouri (32)
Montana (16)
Nebraska (5)
Nevada (32)
New Hampshire (21)
New Jersey (1648)
New Mexico (13)
New York (1763)
North Carolina (827)
North Dakota (6)
Northern California (3484)
Ohio (177)
Oklahoma (11)
Oregon (24)
Pennsylvania (1276)
Puerto Rico (9)
Rhode Island (25)
South America (215)
South Carolina (9)
Southern California (2812)
Tennessee (40)
Texas (906)
United States (23366)
Utah (96)
Virginia (136)
Washington D.C. (37)
Washington State (592)
West Virginia (1)
Wisconsin (45)
282,423 Results for "apollo therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Apollo Neuroscience Announces 2025 Year in Review
February 2, 2026
·
6 min read
Press Releases
Longeveron, Selected as a StartUp Health Alzheimer’s Disease Moonshot Company, Will Participate in StartUp Health Apollo House During JPM Healthcare Week 2026
December 29, 2025
·
5 min read
Press Releases
Marker Therapeutics Provides Update on Phase 1 APOLLO Study Highlighting Encouraging Overall Response Rates in Relapsed Lymphoma
August 26, 2025
·
9 min read
Press Releases
Apollo Therapeutics’ Anti-IL-18 Antibody Camoteskimab Met the Primary Endpoint in a Double-Blind, Randomized, Placebo-Controlled Phase 2a Clinical Trial in Atopic Dermatitis
September 17, 2025
·
7 min read
Press Releases
neurocare group’s Apollo TMS Therapy Devices Now Have FDA Clearance to Treat Adolescents Suffering With Major Depression
September 11, 2025
·
3 min read
Press Releases
Alzheon Announces Peer-Reviewed Scientific Publication of Results from Pivotal APOLLOE4 Phase 3 Trial of Oral Valiltramiprosate/ALZ-801 in APOE4/4 Homozygous Individuals with Early Alzheimer’s Disease
October 15, 2025
·
12 min read
Genetown
Apollo Therapeutics Announces Second Close of Series C Financing Bringing Total Raised in Round to $260 Million
Apollo Therapeutics announces that during December 2023 it completed a second close of its Series C financing, raising an additional $33.5 million and bringing the total raised in this round by the Company during 2023 to $260 million.
January 2, 2024
·
3 min read
Corin Group Announces Clinical Use of Apollo™ Robotic-Assisted Surgical Platform
Corin Group, a pioneer in orthopaedic innovation, announced the successful completion of first cases using the Apollo™ platform and ApolloKnee™ software for robotic-assisted total knee arthroplasty.
May 2, 2024
·
2 min read
Press Releases
Charles River Expands Apollo™ Ecosystem, Offering Bespoke Client Experiences
January 21, 2025
·
4 min read
Drug Development
Principal Investigator from City of Hope National Medical Center Invited to Present Clinical Data from Marker Therapeutics APOLLO Study at 11th Global Summit on Hematologic Malignancies
Marker Therapeutics, Inc. reported that Geoffrey Shouse, D.O., Ph.D., the Principal Investigator at City of Hope National Medical Center in Duarte, CA, was invited to present his clinical experience from the APOLLO study at the 11th Global Summit on Hematologic Malignancies in Whistler, BC, Canada.
April 8, 2024
·
8 min read
1 of 28,243
Next
